# Orion Corporation, Orion Pharma, Espoo, Finland – FDA Inspections

Source: https://www.keypedia.com/companies/orion-corporation-orion-pharma/bc21b600-e8f7-4570-9285-d3c41399fd82

> Inspection records and compliance data for Orion Corporation, Orion Pharma in Espoo. 9 FDA inspections on record, 2 Form 483s, last inspected November 07, 2024.

---

## Details

- Name: Orion Corporation, Orion Pharma
- FEI Number: 3003073605
- Business Operations: API/FDF ANALYTICAL TESTING, CLINICAL BIOEQUIVALENCE OR BIOAVAILABILITY STUDY, FDF MANUFACTURE, IN VITRO BIOEQUIVALENCE OR BIOANALYTICAL TESTING, PACK
- Address Line 1: Orionintie 1
- City: Espoo
- Country Name: Finland
- Address: Orionintie 1, Espoo, Finland
- Country: Finland

## Related Documents

- FDA Inspection 1310408 - Orion Corporation, Orion Pharma - 2024-11-07 — source: FDA, date: November 7, 2024
- FDA Inspection 1310408 - Orion Corporation, Orion Pharma - 2024-11-07 — source: FDA, date: November 7, 2024
- FDA Inspection 1310408 - Orion Corporation, Orion Pharma - 2024-11-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2024
- FDA Inspection 1310408 - Orion Corporation, Orion Pharma - 2024-11-07 — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 7, 2024
- [FDA Inspection 1218973 - Orion Corporation, Orion Pharma - 2022-06-02](https://www.keypedia.com/records/fda_inspections/orion-corporation-orion-pharma/38e0c1e4-84dd-4073-881b-ca638f3e03dc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 2, 2022
- FDA Inspection 1156118 - Orion Corporation, Orion Pharma - 2020-09-17 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 17, 2020
- [FDA Inspection 1053840 - Orion Corporation, Orion Pharma - 2018-06-01](https://www.keypedia.com/records/fda_inspections/orion-corporation-orion-pharma/0d1b8e1b-f117-476b-882c-9cf511f0504d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 1012832 - Orion Corporation, Orion Pharma - 2017-04-21](https://www.keypedia.com/records/fda_inspections/orion-corporation-orion-pharma/9cab18cd-831f-49af-8be8-260958df5255) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 21, 2017
- FDA Inspection 987011 - Orion Corporation, Orion Pharma - 2016-09-13 — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 13, 2016
- FDA Inspection 910768 - Orion Corporation, Orion Pharma - 2014-09-05 — classification: No Action Indicated (NAI), source: FDA, date: September 5, 2014

## Related Companies

- [Delpharm Huningue S.A.S.](https://www.keypedia.com/companies/delpharm-huningue-sas/abe67002-072d-48fc-8ace-21b8021482f7)
- [Haupt Pharma Amareg GmbH](https://www.keypedia.com/companies/haupt-pharma-amareg-gmbh/6badd9f8-b509-4f18-bbcf-4fcd058ba5b3)
- [Kavis Pharma LLC](https://www.keypedia.com/companies/kavis-pharma-llc/453e3985-3964-40f5-aeaf-89cd2cb6f954)
- [American Regent, Inc.](https://www.keypedia.com/companies/american-regent-inc/a73360d0-4ea2-40a4-aa12-221cece9173f)
- [Norbrook Manufacturing Limited](https://www.keypedia.com/companies/norbrook-manufacturing-limited/1de65996-9a81-4594-8fd2-cd6a7caa46c6)
- [FDC Limited](https://www.keypedia.com/companies/fdc-limited/fe9b5d14-5efc-4f5f-9b5b-b4fdd52fc3e8)
- [Zeco, LLC](https://www.keypedia.com/companies/zeco-llc/ff9ce62a-9267-46e9-a42a-7845d479e576)
- [Haupt Pharma Wuelfing GmbH](https://www.keypedia.com/companies/haupt-pharma-wuelfing-gmbh/34339ef4-fb2f-4297-ae5d-191a6adb86b0)
- [AbbVie Inc.](https://www.keypedia.com/companies/abbvie-inc/e9d2de86-ad64-4278-8fb3-a8cd7909719e)
- [Abbott Biologicals BV](https://www.keypedia.com/companies/abbott-biologicals-bv/bf53c085-844a-434e-8500-0f6c23ef9475)